Merz Therapeutics

Merz Therapeutics is a leading pharmaceutical manufacturing company dedicated to addressing the unique needs of individuals affected by movement disorders, neurological conditions, and other health challenges that significantly impact their quality of life. With a strong patient-centric approach, Merz Therapeutics is committed to advancing new and individualized treatment standards, including botulinum toxin, through cutting-edge research and development efforts.

Headquartered in Frankfurt am Main, Germany, at Eckenheimer Landstrasse 100, 60318, DE, Merz Therapeutics has a global presence, serving patients in over 90 countries. The company’s North American affiliate is based in Raleigh, North Carolina, at 6501 Six Forks Road, Raleigh, NC 27615, US. Other key locations include Breakspear Park in Hemel Hempstead, England HP2 4, GB; avenue Gambetta in Paris, FR; and Guglgasse 17 in Vienna, 1110, AT.

Merz Therapeutics is part of the Merz Group, a privately held, family-owned company with over 110 years of experience in developing innovations that address unmet patient and customer needs. Merz Therapeutics continues to build on this legacy, driven by highly-scientific medical affairs resources and dedicated commercial teams, to ensure better outcomes for more patients. We invite the manager of Merz Therapeutics to create a customized and exclusive company showcase and product listing on our platform.